Diana Learoyd
Overview
Explore the profile of Diana Learoyd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papachristos A, Nicholls L, Mechera R, Aniss A, Robinson B, Clifton-Bligh R, et al.
Oncologist
. 2023 Aug;
28(12):1064-1071.
PMID: 37632760
Background: There remains uncertainty regarding the optimal extent of initial surgery and management of recurrent disease in medullary thyroid cancer (MTC). We aim to describe the patterns of disease recurrence...
2.
Worrall B, Papachristos A, Aniss A, Glover A, Sidhu S, Clifton-Bligh R, et al.
Endocr Oncol
. 2023 Jul;
3(1):e220095.
PMID: 37434647
Background: The 2015 American Thyroid Association (ATA) Guidelines permit thyroid lobectomy (TL) or total thyroidectomy in the management of low-risk papillary thyroid cancer (PTC). As definitive risk-stratification is only possible...
3.
Gordon E, Chan D, Arena J, Bernard E, Carr-Boyd E, Clarke S, et al.
J Med Case Rep
. 2021 Oct;
15(1):542.
PMID: 34706762
Background: Neuroendocrine tumors are rare, heterogeneous neoplasms that produce a wide variety of clinical symptoms. Diarrhea in neuroendocrine tumors is incredibly common and is usually benign in nature. We report...
4.
Wijewardene A, Gild M, Nylen C, Schembri G, Roach P, Hoang J, et al.
Eur Thyroid J
. 2021 Sep;
10(5):408-415.
PMID: 34540711
Objective: Our study aimed to analyse temporal trends in radioactive iodine (RAI) treatment for thyroid cancer over the past decade; to analyse key factors associated with clinical decisions in RAI...
5.
Jonker P, Turchini J, Kruijff S, Lin J, Gill A, Eade T, et al.
Ann Surg Oncol
. 2021 Jul;
28(Suppl 3):891.
PMID: 34279756
No abstract available.
6.
Jonker P, Turchini J, Kruijff S, Lin J, Gill A, Eade T, et al.
Ann Surg Oncol
. 2021 May;
28(12):7520-7530.
PMID: 34032961
Background: Patients with anaplastic thyroid cancer (ATC) have poor overall survival, and the optimal management approach remains unclear. The aim of this study is to evaluate our experience with multimodality...
7.
Rodrigo N, Learoyd D, Glastras S
Endocrinol Diabetes Metab Case Rep
. 2021 May;
2021.
PMID: 33982664
Summary: Hypercalcaemia in pregnancy is uncommon, with associated adverse obstetric and perinatal outcomes for both the mother and the fetus. Determination of causality is central to its management. Diagnostic imaging...
8.
Lafontaine N, Learoyd D, Farrel S, Wong R
Clin Endocrinol (Oxf)
. 2021 Feb;
95(2):253-264.
PMID: 33559162
Objective: Acute suppurative thyroiditis (AST) is a rare but potentially fatal condition which can initially be difficult to distinguish from the more common subacute thyroiditis (SAT). We aim to update...
9.
Nylen C, Eriksson F, Yang A, Aniss A, Turchini J, Learoyd D, et al.
Am J Surg
. 2020 Sep;
221(5):886-892.
PMID: 32878695
Background: Prophylactic central lymph node dissection (CLND) in papillary thyroid cancer (PTC) is controversial. We aimed to investigate if prophylactic CLND aids risk stratification and contributes to the decision for...
10.
Ng H, Namboodiri D, Learoyd D, Davidson A, Champion B, Preda V
Endocrinol Diabetes Metab Case Rep
. 2020 Jan;
2019.
PMID: 31967973
Summary: Co-secreting thyrotropin/growth hormone (GH) pituitary adenomas are rare; their clinical presentation and long-term management are challenging. There is also a paucity of long-term data. Due to the cell of...